| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:SDZ 283-910 CAS:164514-54-9 Package:25mg/RMB 10600
|
|
| | L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Basic information |
| | L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Chemical Properties |
| Boiling point | 1059.7±65.0 °C(Predicted) | | density | 1.202±0.06 g/cm3(Predicted) | | pka | 9.27±0.35(Predicted) |
| | L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Usage And Synthesis |
| Description | SDZ 283-910 is a statine-derived inhibitor . | | Uses | SDZ283-910 is a potent human immunodeficiency virus type-1 (HIV-1) protease inhibitor[1]. | | IC 50 | HIV-1 | | References | [1] S Ringhofer, et al. X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: agreement of time-resolved spectroscopy and molecular dynamics simulations. J Mol Biol. 1999 Mar 5;286(4):1147-59. DOI:10.1006/jmbi.1998.2533 |
| | L-Valinamide, N4-[3-methyl-N-[(phenylmethoxy)carbonyl]-L-valyl]-4-amino-2,4,5-trideoxy-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-L-lyxonoyl-N-[(2-hydroxy-4-methoxyphenyl)methyl]- Preparation Products And Raw materials |
|